Cary Street Partners Financial LLC Invests $100,000 in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Cary Street Partners Financial LLC acquired a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 10,667 shares of the pharmacy operator’s stock, valued at approximately $100,000.

A number of other hedge funds also recently bought and sold shares of the business. First Financial Corp IN grew its position in shares of Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 885 shares in the last quarter. Golden State Wealth Management LLC acquired a new position in Walgreens Boots Alliance during the fourth quarter worth $26,000. Riverview Trust Co grew its holdings in Walgreens Boots Alliance by 123.8% in the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after buying an additional 1,590 shares in the last quarter. Venturi Wealth Management LLC purchased a new stake in Walgreens Boots Alliance in the 4th quarter valued at $28,000. Finally, Independence Bank of Kentucky acquired a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth $39,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Evercore ISI boosted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. StockNews.com started coverage on shares of Walgreens Boots Alliance in a report on Monday, May 5th. They set a “hold” rating for the company. Bank of America upped their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Finally, Truist Financial lowered their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus target price of $10.59.

Insider Transactions at Walgreens Boots Alliance

In related news, Chairman Stefano Pessina acquired 832,258 shares of the business’s stock in a transaction dated Sunday, April 27th. The shares were acquired at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the transaction, the chairman now owns 145,621,079 shares of the company’s stock, valued at $1,603,288,079.79. The trade was a 0.57% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 17.50% of the company’s stock.

Walgreens Boots Alliance Stock Up 0.7%

NASDAQ:WBA opened at $11.24 on Monday. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $18.83. The stock’s fifty day moving average is $11.00 and its two-hundred day moving average is $10.30. The stock has a market capitalization of $9.72 billion, a price-to-earnings ratio of -1.10, a price-to-earnings-growth ratio of 1.31 and a beta of 0.77. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.53 by $0.10. The firm had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. Walgreens Boots Alliance’s revenue was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.20 EPS. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.